15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Twist Bioscience Corp, 8 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $41.00 to $120.00 (about 2.9x), a sign of real disagreement on valuation. The average target of $86.00 sits 3% below the current $88.55. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.09 next quarter toward $-0.85 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy889%
Hold111%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Twist Bioscience Corp.
As of Jul, 8 of 9 firms rate TWST a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TWST EPS & revenue forecast
EPS · NEXT QUARTER
$-0.09
Range $-0.12 – $-0.06 · 2 analysts · -80% YoY
Next period, 2 analysts expect Twist Bioscience Corp to earn $-0.09 a share (range $-0.12 – $-0.06), versus $-0.45 a year earlier. Full-year consensus is $-0.77, growing to $-0.85 the year after.
REVENUE · NEXT QUARTER
$117.4M
Range $116.3M – $118.4M · 2 analysts · +19% YoY
Revenue is expected to reach $117.4M (range $116.3M – $118.4M), +18.6% year-over-year. Full-year consensus is $444.7M, rising to $520.0M next year.
Top analysts covering Twist Bioscience Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TWST.
#1
KM
Kyle Mikson
Canaccord Genuity · Rank #192
Buy
$120.00+35.5% to target
Overall win rate
35%
+ Follow
#2
Luke Sergott
Barclays · Rank #194
Buy
$95.00+7.3% to target
Overall win rate
41%
+ Follow
#3
SJ
Sung Ji Nam
Scotiabank · Rank #196
Buy
$62.00-30.0% to target
Overall win rate
45%
+ Follow
#4
Matthew Sykes
Goldman Sachs · Rank #226
Buy
$48.00-45.8% to target
Overall win rate
37%
+ Follow
#5
David Westenberg
Piper Sandler · Rank #227
Buy
$85.00-4.0% to target
Overall win rate
31%
+ Follow
TWST stock forecast FAQ
What is TWST's average 12-month price target?+
The 9 analysts with a live target average $86.00 for Twist Bioscience Corp over the next 12 months, ranging from a $120.00 high to a $41.00 low.
Is TWST stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 8 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TWST?+
The Street-high target is $120.00 (Canaccord Genuity), and the Street-low is $41.00 (Stephens & Co.). The average of all 9 active targets is $86.00.
How many Wall Street analysts cover TWST?+
9 analysts have an active rating on Twist Bioscience Corp, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering TWST?+
Among analysts who currently cover TWST, Kyle Mikson of Canaccord Genuity has the strongest overall Quantellect track record (Rank #192). Their current call is Buy with a $120.00 target.
What is Twist Bioscience Corp's projected EPS for next quarter?+
The consensus estimate is $-0.09 per share (range $-0.12 – $-0.06) across 2 analysts. Full-year EPS is projected at $-0.77, rising to $-0.85 the following year.
How much revenue is Twist Bioscience Corp expected to report next quarter?+
Consensus revenue is $117.4M (range $116.3M – $118.4M). Full-year revenue is projected at $444.7M, growing to $520.0M next year.
Have analysts been upgrading or downgrading TWST lately?+
As of Jul, 8 of 9 firms rate TWST a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TWST calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
